Segment Information (Tables)

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Information

The following table summarizes segment information for the three months ended March 31, 2024, and 2023 (in thousands):

	Three Months Ended March 31,
	2024		2023
Net revenues:
Clinical Services	$	134,535	$	114,869
Advanced Diagnostics	21,705		22,351
Total revenue	156,240		137,220
Cost of revenue:
Clinical Services(1)	76,844		67,292
Advanced Diagnostics(2)	13,927		15,114
Total cost of revenue	90,771		82,406
Gross Profit:
Clinical Services	57,691		47,577
Advanced Diagnostics	7,778		7,237
Total gross profit	65,469		54,814

(1) Clinical Services cost of revenue for both the three months ended March 31, 2024 and 2023 includes $4.3 million of amortization of acquired intangible assets. Clinical Services cost of revenue for the three months ended March 31, 2024 also

includes $0.3 million of non-cash stock-based compensation. There were no such amounts recorded for the three months ended March 31, 2023.

(2) Advanced Diagnostics cost of revenue for both the three months ended March 31, 2024 and 2023 includes $0.6 million of amortization of acquired intangible assets. Advanced Diagnostics cost of revenue for the three months ended March 31, 2024 also includes $0.1 million of non-cash stock-based compensation. There were no such amounts recorded for the three months ended March 31, 2023.